The differences in nuclear NCoR maintenance or loss between different tumor types might reflect differences in the mechanisms driving tumor transformation, differences in tumor stage at the time of diagnosis, or differential usage of particular signaling pathways (i.e. the NF-κB/IKK pathway). The gene discussed is NFKB1; the disease is neoplasm.